A new analysis looking at the effect of PSA screening on prostate cancer mortality over a 25-year period found a more favorable balance of benefits and harms than the 16-year estimates from the ...

Updating its recommendations, a federal government panel now advises against screening for prostate cancer in men aged 75 years and older. The U.S. Preventive Services Task Force (USPSTF) determined ...

Prostate cancer kills more than 10,000 men in England each year. For decades, urologists across the country have been ...

Urologists had championed the prostate cancer test in the past It%27s a %22radical change%22 but a welcome one Risks of incontinence%2C impotence and infection are weighed In a major break from the ...

Prostate cancer specialists oppose plans to restrict screening to only a few thousand men, research has shown.

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.

screening has shifted today, with release of new, more cautious guidelines from the American Urological Association. The Association now says men between 40 and 54 of average risk for prostate cancer ...

Fingerprick PSA Test: Clear Benefits, but Also a Few Concerns Dr Gerald Chodak discusses what we know and what we still need to learn about the Sangia Total PSA Test. Medscape Urology, May 06, 2019 ...

SAN DIEGO — Significant updates on practice-changing clinical trial results in prostate cancer screening, male sexual dysfunction, and female incontinence will be presented during two late-breaking ...

Screening for prostate cancer is a controversial topic within the field of urology. The US Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial did not demonstrate any difference in ...